QUADRISOL I.V. 50 INJECTABLE DIN 02264617
Status: Cancelled Post Market
Holder: INTERVET CANADA CORP
Health Canada record
| Active ingredient(s) | VEDAPROFEN 50 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 28-Jul-2005 |
|---|
| Current status date | 16-Aug-2010 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VEDAPROFEN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02239204 | QUADRISOL 100 | INTERVET CANADA CORP | Gel | VEDAPROFEN 100 MG | Cancelled Post Market |
| 02246927 | QUADRISOL 5 ORAL GEL FOR DOGS | INTERVET CANADA CORP | Gel | VEDAPROFEN 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 6283 | 2005-02-14 | New Drug Submission (NDS) | |
Request a quote for QUADRISOL I.V. 50 INJECTABLE
How to read a Canadian DIN record